Don V. Jackson - Concepedia

Author

Don V. Jackson

Also Known As

D Jackson, D V Jackson, D. V. Jackson, D.V. Jackson, DON V. JACKSON, Don Jackson, Don V Jackson, Don V. Jackson, GRACE ELTA

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Wake Forest University Atrium Health Wake Forest Baptist

About

Don V. Jackson is an author at Wake Forest University specializing in medicine, pharmacotherapy, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	39	1.7K
2	Health Sciences	11	13	593
3	Gastroenterology	3	3	69
4	Social Sciences	1	1	24
5	Hepatology	1	1	20

Don V. Jackson

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Phase III Study of Fluorouracil, Leucovorin, and Levamisole in High-Risk Stage II and III Colon Cancer: Final Report of Intergroup 0089 Daniel G. Haller, Paul J. Catalano, John S. Macdonald, Journal of Clinical Oncology	2005	392
Prophylactic Cranial Irradiation in Small Cell Carcinoma of the Lung Don V. Jackson JAMA Adaptive RadiotherapyNeuro-oncologyRadiation TherapyGliomaMedicine	1977	156
Amelioration of vincristine neurotoxicity by glutamic acid Don V. Jackson, H. Bradley Wells, J. N. Atkins, The American Journal of Medicine Glutamic AcidMedicineNeuroprotectionNeurosciencePharmacology	1988	103
Adriamycin versus methotrexate in five-drug combination chemotherapy for advanced breast cancer. A randomized trial Hyman B. Muss, Dougľas R. White, Frederick Richards, Cancer	1978	93
Cytotoxic thresholds of vincristine in a murine and a human leukemia cell line in vitro. Don V. Jackson, Richard A. Bender PubMed L1210 Murine LeukemiaImmunotoxicologyImmunologyPathologyCellular Pharmacology	1979	92
Pharmacokinetics of vincristine sulfate in adult cancer patients. V.Sagar Sethi, Don V. Jackson, Dougľas R. White, PubMed Vincristine ConcentrationTranslational MedicinePlasma ClearancePhysiologically-based Pharmacokinetic ModelingMedicine	1981	87
Biliary excretion of vincristine Don V. Jackson, Manford C. Castle, Richard A. Bender Clinical Pharmacology & Therapeutics	1978	83
Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology Association. Hyman B. Muss, H. Bradley Wells, Eugene Paschold, Journal of Clinical Oncology Breast OncologyEstrogen ReceptorVersus TamoxifenGynecologyPharmacotherapy	1988	76
High- versus standard-dose megestrol acetate in women with advanced breast cancer: a phase III trial of the Piedmont Oncology Association. Hyman B. Muss, L. Douglas Case, Robert L. Capizzi, Journal of Clinical Oncology Breast OncologyCancer ManagementPharmacotherapyPiedmont Oncology AssociationAdvanced Breast Cancer	1990	73
Prospective evaluation of changes in computed cranial tomography in patients with small cell lung carcinoma treated with chemotherapy and prophylactic cranial irradiation. John B. Craig, Don V. Jackson, D. M. Moody, Journal of Clinical Oncology Cerebral AtrophyOncologic ImagingComputed Cranial TomographyBrain LesionNeuro-oncology	1984	72

Page 1